Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
about
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesCXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factorCXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activationExpression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cellsImmunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrinsMechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells.Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.Stromal cell contribution to human follicular lymphoma pathogenesis.JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemiaCross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survivalBiology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment.Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphomaChemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?Bruton tyrosine kinase (BTK) and its role in B-cell malignancy.Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs.Rho and Rap guanosine triphosphatase signaling in B cells and chronic lymphocytic leukemia.Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.Regulatory effect of chemokines in bone marrow niche.Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.WNT5A: a motility-promoting factor in Hodgkin lymphoma.CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells.Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.The SDF-1 G > A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia.Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis.Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation.Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells.The role of G protein-coupled receptors in lymphoid malignancies.p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.
P2860
Q26866236-035E53C9-5A34-4E2B-974F-763BD618B451Q30487339-C45398AE-4A88-414D-B38D-2B70CB805772Q33385676-6AE8192C-3F2D-4001-B718-169395AC4754Q33654957-FAC13DA3-1A26-4559-9A1F-CF233F7B05EEQ33829089-39C894EA-398F-4749-98DC-6CA84A58BC25Q34078726-C0356E91-73CA-423A-8FE5-C82C4A26BDADQ34161140-B5155196-7779-47A4-ABCB-C8B8BF87A2CBQ35110849-351E67C7-04AC-4CCF-B8DC-C478C8B7875AQ35559414-8F2FA238-F052-43F5-A509-FDE2CB272A4FQ35750964-6D3EA74E-BC4F-470E-A4D4-087D765F64F7Q35876847-5DDE5DF4-560C-488C-AEEF-BB9BE050DBE5Q35910879-06B32C6F-EBE3-4C1B-B01F-C49D0C8EE872Q36201708-769A86EB-A6EA-4642-AEC2-A60F89ADD525Q36208267-3C3C92BD-49DD-4FCF-B662-3239665884C2Q36544062-E309EA9A-94AE-463F-8456-F3F10585D84CQ36561705-A20F730E-74E1-4964-937E-8319C3777A4BQ36862781-BA8D0960-4FDB-4A6A-8769-AF302D7A2B4EQ36958177-0445D34C-59E5-4E62-9538-6994ACF7EAC0Q37427684-5EA866F5-C7BF-4C69-9E58-7564D2820422Q37983913-D1BCCAA0-5549-4C31-BACB-81107B3BD6FDQ37997075-BBCA5A49-7496-4BDF-BD4A-9E1D849D03D2Q38009278-F922361E-4692-4E55-A58C-2132B3801561Q38163044-25E79E85-320A-4957-88C5-67BF243C5A60Q38179980-637190A8-24E7-47AB-9565-8B6EB54A4DABQ38365227-553DDBB7-3F6D-479B-8617-B92BB650FF78Q38506238-CCD61D47-7107-4392-AF5A-730C66711E0EQ38766162-40C0029F-9A17-4B9E-B317-DBC39803282CQ38955569-4C450CAA-0555-425D-84DF-069E7B09E61BQ39034623-CAB43531-FAF3-42B9-9551-75FF414F1980Q39470633-5F3DA0D7-F1DA-4E78-8A3A-D9F6D19F46E7Q39524797-90FC923B-333A-4005-B936-C4332CFEE8BAQ39770651-5CA8475A-AE3D-498E-9E92-4EA07A7A7549Q40241226-91BDD3A1-F049-4808-94A4-28482FA92D5AQ42281477-B121ACFF-C47E-4476-B302-B157981682A7Q43120480-AB3B95DB-2AAE-4364-B0F8-4F4BB3BDF18BQ46238878-8B869128-AB2D-46B5-8D00-91C36D98F893Q47960121-76D2463B-1909-49A1-B3A3-E597647C3A94Q48257200-BB086368-00A8-497E-A63C-DE94F398E1B5Q48264151-E0ABCC5B-0448-46AB-9727-087419564C04Q49539698-964D5530-A656-4CC1-882C-76BFCCF874F7
P2860
Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Chemokine receptors that media ...... espread nodular dissemination.
@ast
Chemokine receptors that media ...... espread nodular dissemination.
@en
Chemokine receptors that media ...... espread nodular dissemination.
@nl
type
label
Chemokine receptors that media ...... espread nodular dissemination.
@ast
Chemokine receptors that media ...... espread nodular dissemination.
@en
Chemokine receptors that media ...... espread nodular dissemination.
@nl
prefLabel
Chemokine receptors that media ...... espread nodular dissemination.
@ast
Chemokine receptors that media ...... espread nodular dissemination.
@en
Chemokine receptors that media ...... espread nodular dissemination.
@nl
P2093
P356
P1476
Chemokine receptors that media ...... espread nodular dissemination.
@en
P2093
Cecilia Muñoz
Elena Fernández-Ruiz
José María Fernández-Rañada
Manuel Alfonso-Pérez
María Cabrerizo
Mónica Sala-Valdés
Nuria E Quintana
Sonia López-Giral
Valle Gómez Garcia De Soria
P304
P356
10.1189/JLB.1203652
P577
2004-05-20T00:00:00Z